WE DO NOT SHIP TO RESIDENTIAL ADDRESSES. For pricing in CAD/AUD/NZD please contact us.

Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) - RPH323Hu02

Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) - RPH323Hu02

Regular price
$266.00
Regular price
Sale price
$266.00
Unit price
per 
Availability
Sold out

Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)

Sizes: 10ug, 50ug, 100ug, 200ug, 500ug, 1mg, Contact us for the 2mg and 5mg sizes

Catalogue Numbers: RPH323Hu02-10, RPH323Hu02-50, RPH323Hu02-100, RPH323Hu02-200, RPH323Hu02-500, RPH323Hu02-1000

Citations, Manuals and MSDS Available upon request.

Target: Preferentially Expressed Antigen In Melanoma

Alternative Names: MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors

Species: Human

Expression System: Prokaryotic expression

Host: E. coli

Uniprot ID: P78395

Gene ID: 23532

Region: Asn416~Leu502

Molecular Weight: 39.9/40kDa

Tags: N-terminal His and GST Tag

Endotoxin Level: <1.0EU per 1µg (determined by the LAL method)

Isoelectric Point: 6.2

Storage: Store at 2-8°C for one month,-80°C for 12 months

Expiration: Stable for 12 months if correctly stored.

Buffer: PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300

State: Freeze-dried powder

Purity: Greater than 90% by SDS-PAGE

Application: Positive Control; Immunogen; SDS-PAGE; WB

Subcellular Location: Membrane, Nucleus

Research Area: Tumor Immunity

Research Use Only